Keeping pharmaceuticals moving post-Brexit
Advice from Tim Harding, customs and tax manager at GEFCO UK, on how to keep medicines moving after the UK departs from the European Union.
6th August 2019
Web Exclusives
Industry's adoption of natural language processing
Adoption of natural language processing and text analytic technologies across healthcare and life science organisations looks set to accelerate with explosive growth in unstructured data and the growing need to gain relevant insight from it.
4th August 2019
Why the ‘total talent’ approach wins in Life Science
Cielo's Tanya Derrick says building a sustainable talent strategy is key to addressing recruitment challenges in the life sciences industry
18th July 2019
Partnering for a global healthcare ecosystem
Prof Sudhesh Kumar, dean of the Warwick Medical School and board member of NHS Digital, on Japan’s ageing society and the lessons for the UK healthcare market
18th July 2019
Getting more from less
Organisational psychologist Jane Piper on why we should be doing less to achieve more
17th July 2019
Taking a wider look at early-stage research
The lack of availability of early-stage research, particularly in online repositories, threatens to hinder scientific progress, says Morressier's Sami Benchekroun
5th July 2019
Pharma has a case of innovation fatigue - here's how to treat it
The pharma innovation story isn’t resonating with vital stakeholders: prescribers and payers working in healthcare settings. Data from a global study which surveyed decision-makers in the healthcare sector reveals that only 39% of respondents in the UK saw the pharmaceutical industry as innovative.
2nd July 2019
Narrowing the provision
The Court of Justice of the European Union (CJEU) has dealt a blow to innovators in two recent significant judgments, addressing questions posed by national courts struggling to judge the eligibility of SPC applications.
25th June 2019
How can the pharma industry turn its sustainability ambitions into action?
Amanda Powel-Smith says pharma has a real opportunity to lead the way in how responsible businesses react to societal challenges
24th June 2019
The creative health revolution
Healthcare communications has always been a bit like Hogwarts. Invisible to most people, massive when you get there, and filled with magic you haven’t yet discovered. There is a creative revolution in healthcare right now.
20th June 2019
Burnout: tech is the cause and solution to this healthcare pandemic
Former surgeon in training Joost Bruggeman discusses the origins of burnout in the healthcare setting and what the NHS needs to do to resolve it.
20th June 2019
Boosting the health of brand protection
Chrissie Jamieson offers her view on what pharma can do to boost brand protection amid the rise of counterfeit medicines
19th June 2019
SmartPeople: Dr Vlado Perkovic
Dr Vlado Perkovictalks to PharmaTimes about his hopes for Novo Nordisk’s FLOW trial, and the need to tackle the growing burden of chronic kidney disease (CKD) in the type II diabetes population.
3rd June 2019
Are PCSK9 inhibitors about to take off?
Richa Munjal considers the current landscape for PCSK9 inhibitors and whether there is a brighter future on the horizon for this class of drugs.
27th May 2019
Outward looking UK scientists among global leaders in the fight against melanoma
Elsevier's Maria de Kleijn-Lloyd looks at UK researchers’ contribution to the fight against melanoma
21st May 2019
